Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. Annan
Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
Cancer Research
Cancer Research
Oncology
Related publications
Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells With Primary Trastuzumab Resistance
Anti-Cancer Agents in Medicinal Chemistry
Cancer Research
Molecular Medicine
Pharmacology
Effects of Herceptin on Circulating Tumor Cells in HER2 Positive Early Breast Cancer
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Mechanisms of Resistance to Trastuzumab and Novel Therapeutic Strategies in HER2-Positive Breast Cancer
International Journal of Breast Cancer
Cancer Research
Oncology
Pharmacology
HER2-positive Breast Cancer With Brain Metastasis, Long Responder to Lapatinib Therapy
AboutOpen
A Nanobody Activation Immunotherapeutic That Selectively Destroys HER2-Positive Breast Cancer Cells
ChemBioChem
Organic Chemistry
Biochemistry
Molecular Medicine
Molecular Biology
Detection of HER2-positive Circulating Tumor Cells Using the LiquidBiopsy® System in Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
A Novel Asymmetrical Anti-Her2/Cd3 Bispecific Antibody Exhibits Potent Cytotoxicity for HER2-positive Tumor Cells
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Patient With Metastatic Breast Cancer, HER2-positive, Trastuzumab- And Pertuzumab-Resistant Responding to Lapatinib
AboutOpen